Advertisement
AMED vs MARB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Hold and MARB is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green while.
- AMED’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 3 TA indicator(s) are bullish.
- AMED’s TA Score: 3 bullish, 5 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а +3.48% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.27%. For the same industry, the average monthly price growth was +1.37%, and the average quarterly price growth was +6.29%.
Reported Earning Dates
AMED is expected to report earnings on Jul 23, 2025.
Industries' Descriptions
@Medical/Nursing Services (-2.27% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
AMED | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 49 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMED | MARB | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 45% | 3 days ago 67% |
| Stochastic ODDS (%) | 3 days ago 52% | 3 days ago 52% |
| Momentum ODDS (%) | 3 days ago 51% | 3 days ago 48% |
| MACD ODDS (%) | 3 days ago 50% | 3 days ago 51% |
| TrendWeek ODDS (%) | 3 days ago 48% | 3 days ago 49% |
| TrendMonth ODDS (%) | 3 days ago 39% | 3 days ago 51% |
| Advances ODDS (%) | 4 days ago 51% | 5 days ago 45% |
| Declines ODDS (%) | 25 days ago 59% | 3 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 56% | 3 days ago 57% |
| Aroon ODDS (%) | 3 days ago 57% | 3 days ago 41% |
Advertisement
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | -0.07% | ||
| FMCQF - AMED | 24% Poorly correlated | N/A | ||
| OPCH - AMED | 23% Poorly correlated | -0.85% | ||
| USPH - AMED | 21% Poorly correlated | -1.46% | ||
| EHAB - AMED | 21% Poorly correlated | -1.91% | ||
| CYH - AMED | 20% Poorly correlated | -1.23% | ||
More | ||||
MARB and
Correlation & Price change
A.I.dvisor tells us that MARB and ACI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MARB and ACI's prices will move in lockstep.
| Ticker / NAME | Correlation To MARB | 1D Price Change % | ||
|---|---|---|---|---|
| MARB | 100% | -0.27% | ||
| ACI - MARB | 24% Poorly correlated | -0.84% | ||
| SRDX - MARB | 23% Poorly correlated | +0.28% | ||
| CHX - MARB | 19% Poorly correlated | +1.87% | ||
| HES - MARB | 18% Poorly correlated | +0.79% | ||
| AMED - MARB | 17% Poorly correlated | -0.07% | ||
More | ||||